<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0001513'>Obesity</z:hpo> is strongly associated with the development of non-alcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease (NAFLD) </plain></SENT>
<SENT sid="1" pm="."><plain>The cytokine osteopontin (OPN) was recently shown to be involved in <z:hpo ids='HP_0001513'>obesity</z:hpo>-induced adipose tissue <z:mp ids='MP_0001845'>inflammation</z:mp> and reduced insulin response </plain></SENT>
<SENT sid="2" pm="."><plain>Accumulating evidence links OPN to the pathogenesis of NAFLD </plain></SENT>
<SENT sid="3" pm="."><plain>Here we aimed to identify the role of OPN in <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo> and impaired hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: <z:mp ids='MP_0002169'>Wild-type</z:mp> (WT) and Opn (also known as Spp1) knockout (Opn (-/-)) mice were fed a high-fat or low-fat diet to study OPN effects in <z:hpo ids='HP_0001513'>obesity</z:hpo>-driven hepatic alterations </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We show that genetic OPN deficiency protected from <z:hpo ids='HP_0001513'>obesity</z:hpo>-induced <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo>, at least in part, by downregulating hepatic triacylglycerol synthesis </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, absence of OPN promoted fat storage in adipose tissue thereby preventing the <z:hpo ids='HP_0001513'>obesity</z:hpo>-induced shift to ectopic fat accumulation in the liver </plain></SENT>
<SENT sid="7" pm="."><plain>Euglycaemic-hyperinsulinaemic clamp studies revealed that <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and excess hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> production in <z:hpo ids='HP_0001513'>obesity</z:hpo> were significantly attenuated in Opn (-/-) mice </plain></SENT>
<SENT sid="8" pm="."><plain>OPN deficiency markedly improved hepatic insulin signalling as shown by enhanced insulin receptor substrate-2 phosphorylation and prevented upregulation of the major hepatic transcription factor Forkhead box O1 and its gluconeogenic target genes </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, <z:hpo ids='HP_0001513'>obesity</z:hpo>-driven <z:mp ids='MP_0001860'>hepatic inflammation</z:mp> and macrophage accumulation was blocked by OPN deficiency </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Our data strongly emphasise OPN as mediator of <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated hepatic alterations including <z:hpo ids='HP_0001397'>steatosis</z:hpo>, <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and excess gluconeogenesis </plain></SENT>
<SENT sid="11" pm="."><plain>Targeting OPN action could therefore provide a novel therapeutic strategy to prevent <z:hpo ids='HP_0001513'>obesity</z:hpo>-related complications such as NAFLD and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>